Publication:
Mechanisms of HIV Protein Degradation into Epitopes: Implications for Vaccine Design

Thumbnail Image

Date

2014

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Rucevic, Marijana, Julie Boucau, Jens Dinter, Georgio Kourjian, and Sylvie Le Gall. 2014. “Mechanisms of HIV Protein Degradation into Epitopes: Implications for Vaccine Design.” Viruses 6 (8): 3271-3292. doi:10.3390/v6083271. http://dx.doi.org/10.3390/v6083271.

Research Data

Abstract

The degradation of HIV-derived proteins into epitopes displayed by MHC-I or MHC-II are the first events leading to the priming of HIV-specific immune responses and to the recognition of infected cells. Despite a wealth of information about peptidases involved in protein degradation, our knowledge of epitope presentation during HIV infection remains limited. Here we review current data on HIV protein degradation linking epitope production and immunodominance, viral evolution and impaired epitope presentation. We propose that an in-depth understanding of HIV antigen processing and presentation in relevant primary cells could be exploited to identify signatures leading to efficient or inefficient epitope presentation in HIV proteomes, and to improve the design of immunogens eliciting immune responses efficiently recognizing all infected cells.

Description

Keywords

HIV, antigen processing, protein degradation, proteasome, aminopeptidase, peptidase, immunogen, vaccine vector, dendritic cells, T cells, viral evolution

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories